Want to buy for someone else? You can purchase a token at check out.
This course is free with a membership upgrade!
Upgrade to a Standard membership and gain access to 1,000+ CE and professional development courses.
Overview
This course provides healthcare professionals with knowledge of hypercoagulability its features, risk factors, and VTE guidelines for prophylaxis and treatment.Goals and Learning Outcomes
Hypercoagulability disorder is a common clinical condition characterized by abnormal blood coagulation, resulting in the formation of blood clots within one’s vasculature. Venous thromboembolism (VTE), or a blood clot found in the veins, is predominantly displayed as deep vein thrombosis (DVT) or pulmonary embolism (PE) (Centers for Disease Control and Prevention, 2022d). DVT may result from the formation of blood clots in the peripheral vascular bed. VTE can occur in multiple sites, including the veins in the lungs, brain, kidneys, liver, mesenteric circulation, arms, and legs. The challenge in managing hypercoagulability disorders is due to the clinical variability of the disease etiology and numerous possible sites of blockage balanced against treatment objectives, outcomes, and cost.
The goal of this course is to provide nurses, pharmacists, dietitians, and physicians in the acute care setting with knowledge of the concept of hypercoagulability and the various features, risk factors, and evidence-based guidelines for prophylaxis and treatment of VTE.
- Identify the concepts of coagulation and hemostasis.
- Recognize the risk factors, symptoms, tests, and diagnostic tools of VTE.
- Recall the treatment modalities and goals of therapy for VTE, using evidence-based practice guidelines for prevention and treatment.
- Determine key points of patient education and the challenges with patient adherence to anticoagulant therapy.
Course Details
Course Originally Released on : 11/1/2022
REL-ACU-0-VTCD
Course Author
II, RPh
RN, BSN
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.